Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adagio Medical Holdings (ADGM) EBITDA Margin (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed EBITDA Margin for 3 consecutive years, with 553.61% as the latest value for Q2 2025.

  • Quarterly EBITDA Margin rose 281030.0% to 553.61% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 1822.29% through Dec 2025, changed N/A year-over-year, with the annual reading at 12200.33% for FY2023, N/A changed from the prior year.
  • EBITDA Margin for Q2 2025 was 553.61% at Adagio Medical Holdings, down from 1174.32% in the prior quarter.
  • The five-year high for EBITDA Margin was 2725.0% in Q3 2024, with the low at 30826.92% in Q1 2024.
  • Average EBITDA Margin over 3 years is 9418.95%, with a median of 2256.69% recorded in 2024.
  • Peak annual rise in EBITDA Margin hit 3200124bps in 2025, while the deepest fall reached 281030bps in 2025.
  • Over 3 years, EBITDA Margin stood at 11065.38% in 2023, then skyrocketed by 125bps to 2725.0% in 2024, then tumbled by -80bps to 553.61% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 553.61%, 1174.32%, and 2725.0% for Q2 2025, Q1 2025, and Q3 2024 respectively.